Skip to main content
NEXALIS THERAPEUTICS LTD logo

NEXALIS THERAPEUTICS LTD — Investor Relations & Filings

Ticker · NX1 ISIN · AU0000456733 ASX Professional, scientific and technical activities
Open in API
Filings indexed 509 across all filing types
Latest filing 2020-12-06 Capital/Financing Update
Country AU Australia
Listing ASX NX1

About NEXALIS THERAPEUTICS LTD

https://nexalistherapeutics.com/

Nexalis Therapeutics Ltd focuses on the discovery and development of innovative small molecule therapies for the treatment of chronic inflammatory and autoimmune diseases. The company utilizes a proprietary drug discovery platform to target specific biological pathways, including the NLRP3 inflammasome, which is implicated in the progression of various systemic and neurodegenerative conditions. By developing highly selective and potent modulators, the organization aims to address significant unmet medical needs in patient populations suffering from debilitating inflammatory disorders. Research and development efforts are centered on translating complex biological insights into clinical-stage therapeutic candidates designed to improve patient outcomes and quality of life through precision targeting of immune system dysregulation.

Recent filings

Filing Released Lang Actions
Proposed issue of Securities - LSH 6 pages 30.8KB
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding a proposed issue of securities by Lifespot Health Ltd. It details the type of issue (standard pro rata issue), the number of securities to be issued, offer price, timetable, and other related information. There are no financial statements or detailed financial performance data included. The content focuses on the capital raising activity and issuance of new shares. This matches the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and capital structure changes. The document length is sufficient and contains substantive details about the securities issue, not just a brief notice or link to a report, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2020-12-06 English
Section 708AA Notice 2 pages 118.1KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 7 December 2020 from Lifespot Health Limited regarding a non-renounceable entitlement offer, which is a type of capital raising. It references section 708AA(2)(f) of the Corporations Act 2001 and details the offer terms, shareholder eligibility, and potential effects on control. The content focuses on a capital raising event and does not contain financial statements or detailed financial performance data. The document length is 3033 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Capital/Financing Update (CAP).
2020-12-06 English
Change in substantial holding 2 pages 584.9KB
Regulatory Filings
2020-11-17 English
Change in substantial holding 3 pages 196.0KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001, titled 'Notice of change of interests of substantial holder.' It details changes in voting power and relevant interests of a substantial shareholder in Lifespot Health Limited. The form includes dates of changes, nature of changes, and voting power percentages. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category 'Major Shareholding Notification' (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory notice about shareholding changes.
2020-11-16 English
Becoming a substantial holder 2 pages 61.9KB
Regulatory Filings
2020-11-16 English
Change in substantial holding 2 pages 118.1KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and shareholdings of substantial holders in Lifespot Health Ltd, including dates and nature of transactions. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category Major Shareholding Notification (MRQ). The document is not a financial report, earnings release, or management report, but a regulatory disclosure of shareholding changes.
2020-11-15 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.